IRIS PubliCatt

De Simone, Clara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4767
NA - Nord America 4308
AS - Asia 953
AF - Africa 67
OC - Oceania 25
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4289
DE - Germania 2130
SE - Svezia 877
CN - Cina 708
UA - Ucraina 569
FR - Francia 312
IT - Italia 290
GB - Regno Unito 174
FI - Finlandia 133
PL - Polonia 127
IN - India 104
CI - Costa d'Avorio 62
BE - Belgio 44
TR - Turchia 42
JP - Giappone 35
RU - Federazione Russa 24
IE - Irlanda 23
IR - Iran 18
AU - Australia 15
CA - Canada 12
NL - Olanda 12
CH - Svizzera 10
ES - Italia 10
NZ - Nuova Zelanda 10
RO - Romania 9
SG - Singapore 8
VN - Vietnam 8
BR - Brasile 7
EU - Europa 7
TW - Taiwan 7
AR - Argentina 5
CZ - Repubblica Ceca 5
MY - Malesia 5
AT - Austria 4
GR - Grecia 4
NG - Nigeria 4
PH - Filippine 4
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
ID - Indonesia 3
IQ - Iraq 3
MK - Macedonia 3
NO - Norvegia 3
GT - Guatemala 2
IL - Israele 2
MX - Messico 2
PE - Perù 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
HK - Hong Kong 1
HU - Ungheria 1
KR - Corea 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10147
Salva come PNG Salva come JPEG
Città #
Chandler 1281
Jacksonville 328
San Mateo 290
Nanjing 201
Ashburn 178
Wilmington 172
Ann Arbor 166
Woodbridge 155
Boston 154
Princeton 127
Dearborn 118
Nürnberg 113
Houston 112
Bremen 98
Cattolica 92
Redwood City 89
Nanchang 81
Kraków 78
Beijing 71
Fairfield 66
Marseille 63
Abidjan 62
Lawrence 61
Seattle 51
Leawood 49
Warsaw 48
Mountain View 47
Detroit 45
Zhengzhou 45
Hebei 42
Brussels 41
Boardman 39
Izmir 39
Hangzhou 38
Redmond 38
Munich 36
Shenyang 35
Menlo Park 33
Kunming 32
Norwalk 31
Milan 28
University Park 28
Tianjin 26
Chicago 25
Jiaxing 24
Rome 24
Guangzhou 20
Paris 19
Fremont 17
Changsha 16
Lancaster 16
Augusta 15
Simi Valley 15
Falls Church 12
Hefei 12
Helsinki 11
Cambridge 10
Shanghai 9
Bologna 7
Tokyo 7
Wuhan 7
Ōtsu 7
Auckland 6
Fuzhou 6
Hanoi 6
Singapore 6
Zurich 6
Andover 5
Ardabil 5
Changchun 5
Dublin 5
Indiana 5
Los Angeles 5
Monmouth Junction 5
New York 5
Sacramento 5
San Diego 5
Tong 5
Vancouver 5
Villa Mercedes 5
Chongqing 4
Jinan 4
Mumbai 4
New Delhi 4
Padova 4
Palermo 4
Philadelphia 4
San Francisco 4
Suri 4
Vienna 4
Bregano 3
Lanzhou 3
Medellín 3
Napoli 3
Ningbo 3
Ottawa 3
Renton 3
San José 3
Seregno 3
Southend 3
Totale 5365
Salva come PNG Salva come JPEG
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 205
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 140
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 135
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 133
High prevalence of celiac disease in psoriasis 128
Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF 126
A Suspected Squamous Cell Carcinoma in a Renal Transplant Recipient Revealing a Rare Cutaneous Phaeohyphomycosis by Alternaria infectoria 121
Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy: case report 121
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 119
Malignant melanoma in a tattoo: case report and review of the literature 117
Cardiomyopathy in scleromyxedema: report of a fatal case. 105
Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis 103
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 103
ENDOTHELIAL DYSFUNCTION IN PSORIASIS PATIENTS: CROSS-SECTIONAL CASE-CONTROL STUDY 100
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 100
A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole 99
Paradoxical skin reactions to biologics in patients with rheumatologic disorders 97
Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B 96
Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea 93
A suspected squamous cell carcinoma in a renal transplant recipient revealed a rare cutaneous phaeohyphomycosis by Alternaria Infectoria 92
Exacerbation of pemphigus after influenza vaccination. 90
Circumscribed pityriasis rubra pilaris type IV 89
Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature 89
Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment 89
Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature 85
amyopatic dermatomyositis: a review by the Italian Group of immunodermatology 85
Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature 85
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. 84
Malabsorption in psoriatic patients: cause or consequence? 84
Linagliptin-induced bullous pemphigoid 83
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 82
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 82
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 82
A) High prevalence of celiac disease in psoriasis. 81
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study 81
Non-Herlitz junctional epidermolysis bullosa without hair involvement associated with BP180 deficiency 79
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 79
The role of immune serological parameters and allergological tests in psoriasis 78
Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study 78
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 78
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients 77
Granulomatous reaction after an aesthetic electroporation procedure 76
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 76
Treatment of Cutaneous Calciphylaxis with Sodium Thiosulfate 74
TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients 73
Management of recurrent cutaneous abscesses during therapy with infliximab 71
Complete clinical remission of psoriasis 6 months after renal transplantation 71
Huriez syndrome: case report with detailed analysis of skin dendritic cells. 69
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 69
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study 69
Validation and field performance of the Italian version of the psoriatic arthritis screening and evaluation (PASE) questionnaire 69
Achilles tendinitis in psoriasis: clinical and sonographic findings 68
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 67
Lichenoid reaction induced by adalimumab 65
Giant verrucous porokeratosis of Mibelli mimicking psoriasis in a patient with psoriasis 65
Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature 65
Increased polymorphonuclear leukocyte Fc gamma-dependent chemiluminescence in active psoriasis is not related to FcRIII (CD16) receptor expression 64
Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas 64
Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers 64
Cutaneous lupus erythematosus mimicking multiple keratoacanthomas 63
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 62
Evaluation of Endothelial Dysfunction in Psoriatic Patients by Different Techniques 62
[Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.] 62
urocanic acid isomers in patients with non-melanma skin cancer 61
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 61
Drug-induced hair colour changes 61
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data. 60
Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy 60
The treatment of onychomycosis with a new form of tioconazole 59
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 58
Follicular mucinosis successfully treated with isotretinoin 58
[Acne fulminans during therapy with isotretinoin] 57
Dermatological signs during inflammatory bowel diseases 57
psoriasiform keratosis 56
Serum beta 2 microglobulin in psoriasis and psoriatic patients 56
Psoriasis awareness among Italian patients: results of a nationwide survey 56
Dyshidrosiform pemphigoid: a well-defined clinical entity? 55
Treatment of severe psoriasis with somatostatin: four years of experience 55
Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine 55
Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene 55
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 55
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports 55
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 55
development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine 54
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project 54
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 54
Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases 53
Propofol-induced irreversible hair depigmentation: A case report 53
Etanercept therapy for psoriasis in a patient with numerous comorbidities 52
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis 52
Detection and management of latent tuberculosis infections before biologic therapy for psoriasis 51
Comparison between ultrasound and magnetic resonance imaging of achilles tendon enthesopathy in patients with psoriasis 51
Psychopathology and eating disorders in patients with psoriasis 51
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 51
Squamous cell carcinoma arising in a venous ulcer as a complication of the Klippel-Trenaunay syndrome 50
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study 50
Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis 49
An unusual case of Koebner phenomenon 49
Role of personalized medication training in improving efficacy and adherence to a topical therapy 49
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 48
Totale 7577
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018286 0000 00 081 55672954
2018/20191048 28348679 149154 14256 388313960
2019/20201504 347726836 104104 15360 10271209178
2020/20211325 5617234135 18068 16364 1663820841
2021/20221464 901392265 7742 31238 48101284327
2022/20232730 457497281562 276480 1770 0000
Totale 10297